Adverum Biotechnologies
ADVM
ADVM
132 hedge funds and large institutions have $937M invested in Adverum Biotechnologies in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 45 increasing their positions, 51 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
71% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 28
74% less call options, than puts
Call options by funds: $3.15M | Put options by funds: $12.3M
Holders
132
Holding in Top 10
3
Calls
$3.15M
Puts
$12.3M
Top Buyers
| 1 | +$14.3M | |
| 2 | +$13.9M | |
| 3 | +$9.95M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.04M |
| 5 |
Rafferty Asset Management
New York
|
+$4.84M |
Top Sellers
| 1 | -$14.2M | |
| 2 | -$10.6M | |
| 3 | -$3.88M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$3.06M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.05M |